Navigating the Limitations and Downsides of GLP-1 Medications

In the past few years, GLP-1 receptor agonists (GLP-1 RAs) have emerged as a promising class of medications for managing type 2 diabetes. These drugs work by mimicking the action of the hormone GLP-1, which stimulates insulin secretion, suppresses glucagon secretion, and slows gastric (stomach and intestine) emptying. While GLP-1 medications offer several benefits, they also come with limitations and downsides that patients and healthcare providers need to consider.
Continue reading